In Vivo Engineering of Immune Cells (IVEIC) for Cancer Immunotherapy (Registration)

OMB No.: 0925-0740
Expiration Date: 9/30/2025

Public reporting burden for this collection of information is estimated to average 3 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.

Your Information

Title

Suffix

First Name:

Last Name:

Email Address:

Confirm email

Phone

City/Town

State/Province

ZIP/Postal Code

Country

Affiliation/Company/Institution/Organization

Title/Position/Career Stage

Additional Registration Questions

Indicate which meeting sessions you would like to attend:

Session 1: Viral- and Synthetic-Based Gene Delivery for In Vivo Engineering and Reprogramming of Immune Cells for Cancer Therapy

Session 2: Precision Genome Editing Technologies for In Vivo Immune Cell Reprogramming

Session 3: Beyond CAR T Cells for In Vivo Engineering and Reprogramming

Session 4: Making In Vivo Engineering and Reprogramming of Immune Cells for Cancer Therapy a Reality

Request for Reasonable Accommodations

No

Yes (please specify)

Please describe requested accommodations: